Over the past 12 months, 2 insiders at Harmony Biosciences Holdings, Inc. filed 7 open-market SEC Form 4 transactions on HRMY: 0 purchases worth $0 and 7 sales worth $3.6M. Insiders have been net sellers over this period. The most recent filing was on Jan 26, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 26, 26 | Sandip KapadiaCHIEF FINANCIAL OFFICER | SELL | 3.7K | $37.15 | $139K |
| Jan 15, 26 | Sandip KapadiaCHIEF FINANCIAL OFFICER | SELL | 21.0K | $35.92 | $753K |
| Dec 12, 25 | Jeffrey M. DaynoPRESIDENT, CEO | SELL | 20.0K | $40.11 | $802K |
| Dec 5, 25 | Sandip KapadiaCHIEF FINANCIAL OFFICER | SELL | 20.0K | $39.54 | $791K |
| Nov 21, 25 | Sandip KapadiaCHIEF FINANCIAL OFFICER | SELL | 3.4K | $35.00 | $120K |
| Aug 15, 25 | Sandip KapadiaCHIEF FINANCIAL OFFICER | SELL | 21.6K | $36.50 | $787K |
| Apr 1, 25 | Sandip KapadiaCHIEF FINANCIAL OFFICER | SELL | 6.2K | $33.12 | $203K |
| Mar 3, 25 | Jeffrey DierksCHIEF COMMERCIAL OFFICER | SELL | 4.4K | $33.23 | $142K |
| Jan 27, 25 | Jeffrey DierksCHIEF COMMERCIAL OFFICER | SELL | 1.6K | $38.02 | $62K |
| Jan 27, 25 | Sandip KapadiaCHIEF FINANCIAL OFFICER | SELL | 1.8K | $38.05 | $68K |
| Jan 24, 25 | Jeffrey DierksCHIEF COMMERCIAL OFFICER | SELL | 8.0K | $37.87 | $296K |
| Jan 21, 25 | Jeffrey M. DaynoPRESIDENT, CEO | SELL | 19.3K | $40.13 | $774K |
| Jan 21, 25 | Sandip KapadiaCHIEF FINANCIAL OFFICER | SELL | 25.0K | $40.18 | $1.0M |
| Jan 21, 25 | Jeffrey DierksCHIEF COMMERCIAL OFFICER | SELL | 1.1K | $40.00 | $45K |
| Jan 16, 25 | Jeffrey DierksCHIEF COMMERCIAL OFFICER | SELL | 29.5K | $37.41 | $1.1M |
| Jan 15, 25 | Jeffrey DierksCHIEF COMMERCIAL OFFICER | SELL | 10.5K | $37.01 | $389K |
| Jan 13, 25 | Jeffrey DierksCHIEF COMMERCIAL OFFICER | SELL | 7.2K | $37.04 | $266K |
| Nov 5, 24 | Marshman Fund Trust IITenPercentOwner | SELL | 600.0K | $30.30 | $18.2M |
| Nov 5, 24 | Valor Equity Partners Iv-b L.p.TenPercentOwner | SELL | 600.0K | $30.30 | $18.2M |
| Nov 1, 24 | Marshman Fund Trust IITenPercentOwner | SELL | 4.00M | $30.30 | $121.2M |
| Nov 1, 24 | Valor Equity Partners Iv-b L.p.TenPercentOwner | SELL | 4.00M | $30.30 | $121.2M |
| Oct 29, 24 | Jeffrey DierksCHIEF COMMERCIAL OFFICER | SELL | 21.5K | $40.47 | $870K |
| Oct 3, 24 | Jeffrey DierksCHIEF COMMERCIAL OFFICER | SELL | 35.7K | $35.62 | $1.2M |
| Oct 1, 24 | Jeffrey DierksCHIEF COMMERCIAL OFFICER | SELL | 400 | $40.19 | $16K |
| Sep 30, 24 | Jeffrey DierksCHIEF COMMERCIAL OFFICER | SELL | 35.8K | $40.03 | $1.4M |
| Sep 27, 24 | Jeffrey DierksCHIEF COMMERCIAL OFFICER | SELL | 200 | $40.05 | $8K |
| Mar 15, 24 | Jeffrey DierksCHIEF COMMERCIAL OFFICER | SELL | 12.0K | $32.00 | $383K |
| Mar 8, 24 | Jeffrey DierksCHIEF COMMERCIAL OFFICER | SELL | 194 | $32.00 | $6K |
| Dec 14, 22 | Jack NielsenDirector | SELL | 2.8K | $59.96 | $170K |
| Dec 14, 22 | Andreas WickiDirector | SELL | 130 | $60.00 | $8K |
| Dec 13, 22 | Andreas WickiDirector | SELL | 6.3K | $60.13 | $380K |
| Dec 12, 22 | Andreas WickiDirector | SELL | 22.4K | $60.36 | $1.4M |
| Dec 9, 22 | Jack NielsenDirector | SELL | 9.8K | $59.89 | $590K |
| Dec 8, 22 | Jack NielsenDirector | SELL | 36.9K | $59.90 | $2.2M |
| Dec 7, 22 | Jack NielsenDirector | SELL | 64.0K | $60.35 | $3.9M |
| Dec 5, 22 | Andreas WickiDirector | SELL | 77.9K | $61.23 | $4.8M |
| Dec 2, 22 | Andrew SerafinCHIEF STRATEGY OFFICER | SELL | 37.1K | $60.71 | $2.2M |
| Dec 1, 22 | Jack NielsenDirector | SELL | 65.7K | $60.00 | $3.9M |
| Nov 30, 22 | Jack NielsenDirector | SELL | 42.7K | $58.93 | $2.5M |
| Nov 29, 22 | Jack NielsenDirector | SELL | 21.3K | $57.82 | $1.2M |
| Nov 22, 22 | Jack NielsenDirector | SELL | 31.9K | $57.60 | $1.8M |
| Nov 21, 22 | Jack NielsenDirector | SELL | 24.9K | $57.08 | $1.4M |
| Nov 18, 22 | Jack NielsenDirector | SELL | 20.8K | $57.00 | $1.2M |
| Nov 15, 22 | Andreas WickiDirector | SELL | 11.0K | $60.10 | $659K |
| Nov 15, 22 | Jack NielsenDirector | SELL | 62.9K | $56.80 | $3.6M |
| Nov 14, 22 | Andreas WickiDirector | SELL | 40.3K | $59.10 | $2.4M |
| Nov 14, 22 | Jack NielsenDirector | SELL | 58.7K | $58.70 | $3.4M |
| Nov 11, 22 | Jack NielsenDirector | SELL | 36.8K | $57.14 | $2.1M |
| Nov 10, 22 | Andreas WickiDirector | SELL | 95.2K | $58.80 | $5.6M |
| Nov 9, 22 | Andreas WickiDirector | SELL | 15.3K | $58.05 | $888K |
Over the past 12 months, insiders at Harmony Biosciences Holdings, Inc. filed 0 open-market purchases worth $0 and 7 sales worth $3.6M on HRMY, which makes them net sellers over the period. The most recent Form 4 was filed on Jan 26, 26.
2 different insiders at Harmony Biosciences Holdings, Inc. filed open-market SEC Form 4 transactions on HRMY over the last 12 months.
InsiderTape plots every HRMY insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Harmony Biosciences Holdings, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →